May 10, 2018 / 11:40 AM / a month ago

BRIEF-Strongbridge Biopharma Reports Q1 Non-GAAP Loss Per Share Of $0.33

Reuters Staff

1 Min Read

May 10 (Reuters) - Strongbridge Biopharma plc:

* REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* Q1 NON-GAAP LOSS PER SHARE $0.33

* Q1 EARNINGS PER SHARE VIEW $-0.40 — THOMSON REUTERS I/B/E/S

* INCREASED FULL-YEAR 2018 REVENUE GUIDANCE FOR KEVEYIS TO $18 TO $20 MILLION

* STRONGBRIDGE HAD $92.4 MILLION OF CASH AND CASH EQUIVALENTS AND $86.5 MILLION IN OUTSTANDING DEBT AS OF MARCH 31, 2018

* MACRILEN (MACIMORELIN) PRODUCT LAUNCH ON TRACK FOR JULY 2018 Source text for Eikon: Further company coverage:

0 : 0